1. Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium,
calcium, and fiber and risk of stroke among US men. Circulation
1998;98:1198–204.
2. Sasaki S, Zhang XH, Kesteloot H. Dietary sodium, potassium, saturated
fat, alcohol, and stroke mortality. Stroke 1995;26:783–9.
3. Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated
mortality. A 12-year prospective population study. N Engl J Med
1987;316:235–40.
4. Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium,
calcium, and fiber and risk of stroke among US men. Circulation
1998;98:1198–204.
5. Fang J, Madhavan S, Alderman MH. Dietary Potassium Intake and Stroke
Mortality. Stroke 2000;31:1532–7.
6. Yamori Y, Nara Y, Mizushima S, et al. Nutritional factors for stroke
and major cardiovascular diseases: international epidemiological comparison of dietary
prevention. Health Rep 1994;6:22–7.
7. Stamler J, Caggiula AW, Grandits GA. Relation of body mass and
alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention
and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr
1997;65:338S–65S.
8. Suter PM. The effects of potassium, magnesium, calcium, and fiber on
risk of stroke. Nutr Rev 1999;57:84–8.
9. Rodriguez Artalejo F, Guallar-Castillon P, Banegas Banegas JR, et al.
Consumption of fruit and wine and the decline in cerebrovascular disease mortality in Spain
(1975–1993). Stroke 1998;29:1556–61.
10. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease:
a review. Int J Epidemiol 1997;26:1–13.
11. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable
intake in relation to risk of ischemic stroke. JAMA 1999;282:1233–9.
12. Liu S, Manson JE, Stampfer MJ, et al. Whole grain consumption and
risk of ischemic stroke in women. A prospective study. JAMA
2000;284:1534–40.
13. Gillman MW, Cupples LA, Millen BE, et al. Inverse association of
dietary fat with development of ischemic stroke in men. JAMA
1997;278:2145–50.
14. Seino F, Date C, Nakayama T, et al. Dietary lipids and incidence of
cerebral infarction in a Japanese rural community. J Nutr Sci Vitaminol (Tokyo)
1997;43:83–99.
15. Brunner R. Dietary fat and ischemic stroke. JAMA
1998;279:1171–2 [letter].
16. Ornish D. Dietary fat and ischemic stroke. JAMA
1998;279:1172 [letter].
17. Stein HD. Dietary fat and ischemic stroke. JAMA
1998;279:1172 [letter].
18. Sasaki S, Zhang XH, Kesteloot H. Dietary sodium, potassium, saturated
fat, alcohol, and stroke mortality. Stroke 1995;26:783–9.
19. Ricci S, Celani MG, Righetti E, et al. Fatty acid dietary intake and
the risk of ischaemic stroke: a multicentre case-control study. UFA Study Group. J
Neurol 1997;244:360–4.
20. Gillman MW, Cupples LA, Millen BE, et al. Inverse association of
dietary fat with development of ischemic stroke in men. JAMA
1997;278:2145–50.
21. Seino F, Date C, Nakayama T, et al. Dietary lipids and incidence of
cerebral infarction in a Japanese rural community. J Nutr Sci Vitaminol (Tokyo)
1997;43:83–99.
22. Zhang J, Sasaki S, Amano K, et al. Fish consumption and mortality
from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med
1999;28:520–9.
23. Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke.
The Zutphen Study. Stroke 1994;25:328–32.
24. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3
fatty acids and risk of stroke in women. JAMA 2001;285:304–12.
25. Orencia AJ, Daviglus ML, Dyer AR, et al. Fish consumption and stroke
in men. 30-year findings of the Chicago Western Electric Study. Stroke
1996;27:204–9.
26. Morris MC, Manson JE, Rosner B, et al. Fish consumption and
cardiovascular disease in the physicians’ health study: a prospective study. Am J
Epidemiol 1995;142:166–75.
27. Sasaki S, Zhang XH, Kesteloot H. Dietary sodium, potassium, saturated
fat, alcohol, and stroke mortality. Stroke 1995;26:783–9.
28. Tobian L. Dietary sodium chloride and potassium have effects on the
pathophysiology of hypertension in humans and animals. Am J Clin Nutr
1997;65:606S–11S [review].
29. Perry IJ, Beevers DG. Salt intake and stroke: a possible direct
effect. J Hum Hypertens 1992;6:23–5.
30. He J, Ogden LG, Vupputuri S, et al. Dietary sodium intake and
subsequent risk of cardiovascular disease in overweight adults. JAMA
1999;282:2027–34.
31. Antonios TF, MacGregor GA. Salt intake: potential deleterious effects
excluding blood pressure. J Hum Hypertens 1995;9:511–5 [review].
32. Hillbom M. Alcohol consumption and stroke: benefits and risks.
Alcohol Clin Exp Res 1998;22:352S–8S [review].
33. Caicoya M, Rodriguez T, Corrales C, et al. Alcohol and stroke: a
community case-control study in Asturias, Spain. J Clin Epidemiol
1999;52:677–84.
34. Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic
stroke. JAMA 1986;255:2311–4.
35. Romelsjö A, Leifman A. Association between alcohol consumption
and mortality, myocardial infarction, and stroke in 25 year follow up of 49,618 young Swedish
men. BMJ 1999;319:821–2.
36. Thrift AG, Donnan GA, McNeil JJ. Heavy drinking, but not moderate or
intermediate drinking, increases the risk of intracerebral hemorrhage. Epidemiology
1999;10:307–12.
37. Caicoya M, Rodriguez T, Corrales C, et al. Alcohol and stroke: a
community case-control study in Asturias, Spain. J Clin Epidemiol
1999;52:677–84.
38. Hillbom M. Alcohol consumption and stroke: benefits and risks.
Alcohol Clin Exp Res 1998;22:352S–8S [review].
39. Shinton R. Lifelong exposures and the potential for stroke
prevention: the contribution of cigarette smoking, exercise, and body fat. J Epidemiol
Community Health 1997;51:138–43.
40. Jacobs DR Jr, Adachi H, Mulder I, et al. Cigarette smoking and
mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern
Med 1999;159:733–40.
41. Shinton R, Beevers G. Meta-analysis of relation between cigarette
smoking and stroke. BMJ 1989;298:789–94.
42. You RX, Thrift AG, McNeil JJ, et al. Ischemic stroke risk and passive
exposure to spouses’ cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS)
Group. Am J Public Health 1999;89:572–5.
43. Lee IM, Hennekens CH, Berger K, et al. Exercise and risk of stroke in
male physicians. Stroke 1999;30:1–6.
44. Sacco RL, Gan R, Boden-Albala B, et al. Leisure-time physical
activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke
1998;29:380–7.
45. Agnarsson U, Thorgeirsson G, Sigvaldason H, et al. Effects of
leisure-time physical activity and ventilatory function on risk for stroke in men: the
Reykjavik Study. Ann Intern Med 1999;130:987–90.
46. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N
Engl J Med 1995;333:1392–400 [review].
47. Evenson KR, Rosamond WD, Cai J, et al. Physical activity and ischemic
stroke risk : the atherosclerosis risk in communities study. Stroke
1999;30:1333–9.
48. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of
body mass index, weight change, and risk of stroke in women. JAMA
1997;277:1539–45.
49. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N
Engl J Med 1995;333:1392–400 [review].
50. Megnien JL, Denarie N, Cocaul M, et al. Predictive value of
waist-to-hip ratio on cardiovascular risk events. Int J Obes Relat Metab Disord
1999;23:90–7.
51. Walker SP, Rimm EB, Ascherio A, et al. Body size and fat distribution
as predictors of stroke among US men. Am J Epidemiol 1996;144:1143–50.
52. Folsom AR, Prineas RJ, Kaye SA, et al. Incidence of hypertension and
stroke in relation to body fat distribution and other risk factors in older women.
Stroke 1990;21:701–6.
53. Gulyas B, Bonoczk P, Vas A, et al. [The effect of a single-dose
intravenous vinpocetine on brain metabolism in patients with ischemic stroke.] Orv
Hetil 2001;142:443–9 [in Hungarian].
54. Szakall S, Boros I, Balkay L, et al. Cerebral effects of a single
dose of intravenous vinpocetine in chronic stroke patients: a PET study. J
Neuroimaging 1998;8:197–204.
55. Feigin VL, Doronin BM, Popova TF, et al. Vinpocetine treatment in
acute ischaemic stroke: a pilot single-blind randomized clinical trial. Eur J Neurol
2001;8:81–5.
56. Bereczki D, Fekete I. A systematic review of vinpocetine therapy in
acute ischaemic stroke. Eur J Clin Pharmacol 1999;55:349-52 [review].
57. Bereczki D, Fekete I. Vinpocetine for acute ischaemic stroke.
Cochrane Database Sys Rev 2000;2:CD000480.
58. Lalouschek W, Aull S, Serles W, et al. Genetic and nongenetic factors
influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and
in healthy control subjects. J Lab Clin Med 1999;133:575–82.
59. Ridker PM, Manson JE, Buring JE, et al. Homocysteine and risk of
cardiovascular disease among postmenopausal women. JAMA 1999;281:1817–21.
60. Perry IJ. Homocysteine, hypertension and stroke. J Hum
Hypertens 1999;13:289–93 [review].
61. Genest J Jr. Hyperhomocyst(e)inemia—determining factors and
treatment. Can J Cardiol 1999;15:35B–38B [review].
62. Ubbink JB, Hayward WJ, van der Merwe A, et al. Vitamin requirements
for the treatment of hyperhomocysteinemia in humans. J Nutr
1994;124:1927–33.
63. Manson JB, Miller JW. The effects of vitamin B12, B6, and folate on
blood homocysteine levels. Ann NY Acad Sci 1992;669:197–204 [review].
64. Bonithon-Kopp C, Coudray C, Berr C, et al. Combined effects of lipid
peroxidation and antioxidant status on carotid atherosclerosis in a population aged
59–71 y: The EVA Study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr
1997;65:121–7.
65. Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and
carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study.
Circulation 1995;92:2142–50.
66. Tomeo AC, Geller M, Watkins TR, et al. Antioxidant effects of
tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids
1995;30:1179–83.
67. Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with
aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr 1995;62(6
Suppl):1381–4S.
68. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in
Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence,
and disease-specific mortality in the general population. J Natl Cancer Inst
1993;85:1483–92.
69. Gaziano JM, Manson JE, Ridker PM, et al. Beta-carotene therapy for
chronic stable angina. Circulation 1990;82(Suppl III):III–201 [abstract].
70. Ascherio A, Rimm EB, Hernan MA, et al. Relation of consumption of
vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States.
Ann Intern Med 1999;130:963–70.
71. Mark SD, Wang W, Fraumeni JF Jr, et al. Do nutritional supplements
lower the risk of stroke or hypertension? Epidemiology 1998;9:9–15.
72. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of
long-term supplementation with beta carotene on the incidence of malignant neoplasms and
cardiovascular disease. N Engl J Med 1996;334:1145–9.
73. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group.
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in
male smokers. N Engl J Med 1994;330:1029–35.
74. Leppala JM, Virtamo J, Fogelholm R, et al. Controlled trial of
alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male
smokers. Arterioscler Thromb Vasc Biol 2000;20:230–5.
75. Leppala JM, Virtamo J, Fogelholm R, et al. Vitamin E and beta
carotene supplementation in high risk for stroke: a subgroup analysis of the alpha-tocopherol,
beta-carotene cancer prevention study. Arch Neurol 2000;57:1503–9.
76. Kopecky SL, Gersh BJ, McGoon MD, et al. Lone atrial fibrillation in
elderly persons: a marker for cardiovascular risk. Arch Intern Med
1999;159:1118–22.
77. Bordia A, Verma SK, Srivastava KC. Effect of garlic (Allium
sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients
with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids
1998;58:257–63.
78. Berthold HK, Sudhop T. Garlic preparations for prevention of
atherosclerosis. Curr Opin Lipidol 1998;9:565–9 [review].
79. Kiesewetter H, Jung F, Pindur G, et al. Effect of garlic on
thrombocyte aggregation, microcirculation and other risk factors. Int J Pharm Ther
Toxicol 1991;29:151–4.
80. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N
Engl J Med 1988;318:549–57 [review].
81. Calzada C, Bruckdorfer KR, Rice-Evans CA. The influence of
antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis
1997;128:97–105.
82. Steiner M. Vitamin E: more than an antioxidant. Clin Cardiol
1993;16:I16–8 [review].
83. Heemskerk JW, Vossen RC, van Dam-Mieras MC. Polyunsaturated fatty
acids and function of platelets and endothelial cells. Curr Opin Lipidol
1996;7:24–9 [review].
84. Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium,
magnesium, calcium, and fiber and risk of stroke among US men. Circulation
1998;98:1198–204.
85. Yang CY. Calcium and magnesium in drinking water and risk of death
from cerebrovascular disease. Stroke 1998;29:411–4.
86. Muir KW. New experimental and clinical data on the efficacy of
pharmacological magnesium infusions in cerebral infarcts. Magnes Res
1998;11:43–56.
87. Muir KW, Lees KR. A randomized, double-blind, placebo-controlled
pilot trial of intravenous magnesium sulfate in acute stroke. Stroke
1995;26:1183–8.